Variant estrogen receptor α mRNAs in human breast cancer specimens

• Published in: International journal of cancer 2000-10, Vol.88 (2), p.209-216
• Main Authors: Anandappa, Shanez Y., Sibson, Ross, Platt‐Higgins, Angela, Winstanley, John H.R., Rudland, Philip S., Barraclough, Roger
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Blotting, Northern; Breast - pathology; Breast Neoplasms - genetics; Breast Neoplasms - pathology; Cloning, Molecular; Estrogen Receptor alpha; Female; Genetic Variation; Gynecology. Andrology. Obstetrics; Humans; Mammary gland diseases; Medical sciences; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Estrogen - genetics; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - analysis; Sequence Deletion; Transcription, Genetic; Tumors
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/1097-0215(20001015)88:2<209::AID-IJC10>3.0.CO;2-M

A panel of human breast cancer specimens was examined for single base change mutations by DNA sequencing and for larger deletions using a PCR‐based assay. In the cancer specimens examined, no sequencing variants were detected other than a previously characterized polymorphism. Although most of the specimens contained estrogen receptor (ER) variants at a low level, 2 of 118 specimens exhibited variants which, after amplification, constituted most of the amplified ER cDNA. One specimen contained a single variant form, and there was little evidence of the wild‐type ER mRNA by PCR, Northern blotting or immunocytochemistry. The second specimen, despite the presence of a normal‐sized mRNA by Northern blotting and normal immunocytochemical staining for ER, contained at least 5 different variant forms as well as the wild‐type ER. All but 1 of the variant forms were processing variants, and 3 of these processing variants have not been described before. One variant, although lacking exons 2–4, has break points in exons 1 and 5 that do not correspond to intron–exon boundaries. This variant might reflect more widespread damage to the genome in this breast cancer specimen. The low level of occurrence of variants suggests that ER variant forms, at least in the coding region, do not contribute generally to the progression of breast cancer. Int. J. Cancer 88:209–216, 2000. © 2000 Wiley‐Liss, Inc.